ID   MRCKB_RAT               Reviewed;        1713 AA.
AC   Q7TT49; O54875;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   24-JUL-2024, entry version 171.
DE   RecName: Full=Serine/threonine-protein kinase MRCK beta;
DE            EC=2.7.11.1;
DE   AltName: Full=CDC42-binding protein kinase beta;
DE   AltName: Full=DMPK-like beta;
DE   AltName: Full=Myotonic dystrophy kinase-related CDC42-binding kinase beta;
DE            Short=MRCK beta;
DE            Short=Myotonic dystrophy protein kinase-like beta;
GN   Name=Cdc42bpb {ECO:0000312|EMBL:AAP34403.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC02942.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain {ECO:0000312|EMBL:AAC02942.1};
RX   PubMed=9418861; DOI=10.1128/mcb.18.1.130;
RA   Leung T., Chen X.-Q., Tan I., Manser E., Lim L.;
RT   "Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42
RT   effector in promoting cytoskeletal reorganization.";
RL   Mol. Cell. Biol. 18:130-140(1998).
RN   [2] {ECO:0000312|EMBL:AAP34403.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Huang C.Q., Wu S.L., Cheng Z.;
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, AND INTERACTION WITH LURAP1 AND MYO18A.
RX   PubMed=18854160; DOI=10.1016/j.cell.2008.09.018;
RA   Tan I., Yong J., Dong J.M., Lim L., Leung T.;
RT   "A tripartite complex containing MRCK modulates lamellar actomyosin
RT   retrograde flow.";
RL   Cell 135:123-136(2008).
RN   [4]
RP   FUNCTION, INTERACTION WITH TJP1, MUTAGENESIS OF PHE-952; TYR-954; LEU-964
RP   AND PHE-966, AND SUBCELLULAR LOCATION.
RX   PubMed=21240187; DOI=10.1038/emboj.2010.353;
RA   Huo L., Wen W., Wang R., Kam C., Xia J., Feng W., Zhang M.;
RT   "Cdc42-dependent formation of the ZO-1/MRCKbeta complex at the leading edge
RT   controls cell migration.";
RL   EMBO J. 30:665-678(2011).
RN   [5]
RP   FUNCTION IN PHOSPHORYLATION OF PPP1R12A AND MYL9/MLC2, AND ACTIVITY
RP   REGULATION.
RX   PubMed=21457715; DOI=10.1016/j.febslet.2011.03.054;
RA   Tan I., Lai J., Yong J., Li S.F., Leung T.;
RT   "Chelerythrine perturbs lamellar actomyosin filaments by selective
RT   inhibition of myotonic dystrophy kinase-related Cdc42-binding kinase.";
RL   FEBS Lett. 585:1260-1268(2011).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1688; SER-1692 AND SER-1695,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7]
RP   INTERACTION WITH FAM89B AND LURAP1.
RC   TISSUE=Brain;
RX   PubMed=25107909; DOI=10.1074/jbc.m114.588079;
RA   Lee I.C., Leung T., Tan I.;
RT   "Adaptor protein LRAP25 mediates myotonic dystrophy kinase-related Cdc42-
RT   binding kinase (MRCK) regulation of LIMK1 protein in lamellipodial F-actin
RT   dynamics.";
RL   J. Biol. Chem. 289:26989-27003(2014).
CC   -!- FUNCTION: Serine/threonine-protein kinase which is an important
CC       downstream effector of CDC42 and plays a role in the regulation of
CC       cytoskeleton reorganization and cell migration. Regulates actin
CC       cytoskeletal reorganization via phosphorylation of PPP1R12C and
CC       MYL9/MLC2 (PubMed:21240187, PubMed:21457715). In concert with MYO18A
CC       and LURAP1, is involved in modulating lamellar actomyosin retrograde
CC       flow that is crucial to cell protrusion and migration. Phosphorylates
CC       PPP1R12A (PubMed:18854160). In concert with FAM89B/LRAP25 mediates the
CC       targeting of LIMK1 to the lamellipodium resulting in its activation and
CC       subsequent phosphorylation of CFL1 which is important for lamellipodial
CC       F-actin regulation (By similarity). {ECO:0000250|UniProtKB:Q7TT50,
CC       ECO:0000269|PubMed:18854160, ECO:0000269|PubMed:21240187,
CC       ECO:0000269|PubMed:21457715}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q5VT25};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q5VT25};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q5VT25};
CC   -!- ACTIVITY REGULATION: Maintained in an inactive, closed conformation by
CC       an interaction between the kinase domain and the negative
CC       autoregulatory C-terminal coiled-coil region. Agonist binding to the
CC       phorbol ester binding site disrupts this, releasing the kinase domain
CC       to allow N-terminus-mediated dimerization and kinase activation by
CC       transautophosphorylation (By similarity). Inhibited by chelerythrine
CC       chloride. {ECO:0000250, ECO:0000269|PubMed:21457715}.
CC   -!- SUBUNIT: Homodimer and homotetramer via the coiled coil regions.
CC       Interacts tightly with GTP-bound but not GDP-bound CDC42 (By
CC       similarity). Interacts with TJP1; this interaction requires the
CC       presence of catalytically active CDC42 (PubMed:21240187). Forms a
CC       tripartite complex with MYO18A and LURAP1 with the latter acting as an
CC       adapter connecting CDC42BPB and MYO18A. LURAP1 binding results in
CC       activation of CDC42BPB by abolition of its negative autoregulation
CC       (PubMed:18854160). Interacts with STRIP1, STRN3 and SIKE1 (By
CC       similarity). Interacts with CPNE4 (via VWFA domain) (By similarity).
CC       Interacts with LURAP1 (PubMed:25107909). Interacts (via AGC-kinase C-
CC       terminal domain) with FAM89B/LRAP25 (via LRR repeat) (PubMed:25107909).
CC       Forms a tripartite complex with FAM89B/LRAP25 and LIMK1 (By
CC       similarity). {ECO:0000250|UniProtKB:Q7TT50,
CC       ECO:0000250|UniProtKB:Q9Y5S2, ECO:0000269|PubMed:18854160,
CC       ECO:0000269|PubMed:21240187, ECO:0000269|PubMed:25107909}.
CC   -!- INTERACTION:
CC       Q7TT49; D4A8G3: Lurap1; NbExp=4; IntAct=EBI-692673, EBI-2015467;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000269|PubMed:21240187}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:21240187}; Cytoplasmic side
CC       {ECO:0000269|PubMed:21240187}. Cell junction
CC       {ECO:0000269|PubMed:21240187}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:Q3UU96}. Note=Displays a dispersed punctate
CC       distribution and concentrates along the cell periphery, especially at
CC       the leading edge and cell-cell junction. This concentration is PH-
CC       domain dependent (By similarity). Detected at the leading edge of
CC       migrating and wounded cells; this localization requires the presence of
CC       catalytically active CDC42 (PubMed:21240187). Localizes in the
CC       lamellipodium in a FAM89B/LRAP25-dependent manner (By similarity).
CC       {ECO:0000250|UniProtKB:O54874, ECO:0000250|UniProtKB:Q3UU96,
CC       ECO:0000269|PubMed:21240187}.
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined with highest
CC       levels in lung and kidney. {ECO:0000269|PubMed:9418861}.
CC   -!- PTM: Proteolytically cleaved by caspases upon apoptosis induction.
CC       {ECO:0000250|UniProtKB:Q9Y5S2}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. DMPK subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC02942.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF021936; AAC02942.1; ALT_FRAME; mRNA.
DR   EMBL; AY277590; AAP34403.1; -; mRNA.
DR   PIR; T14050; T14050.
DR   RefSeq; NP_446072.2; NM_053620.3.
DR   AlphaFoldDB; Q7TT49; -.
DR   SMR; Q7TT49; -.
DR   IntAct; Q7TT49; 16.
DR   MINT; Q7TT49; -.
DR   STRING; 10116.ENSRNOP00000036487; -.
DR   iPTMnet; Q7TT49; -.
DR   PhosphoSitePlus; Q7TT49; -.
DR   jPOST; Q7TT49; -.
DR   PaxDb; 10116-ENSRNOP00000036487; -.
DR   Ensembl; ENSRNOT00000039059.4; ENSRNOP00000036487.2; ENSRNOG00000009675.6.
DR   Ensembl; ENSRNOT00055051813; ENSRNOP00055042750; ENSRNOG00055029879.
DR   Ensembl; ENSRNOT00060044719; ENSRNOP00060037070; ENSRNOG00060025767.
DR   Ensembl; ENSRNOT00065043009; ENSRNOP00065035208; ENSRNOG00065024999.
DR   GeneID; 113960; -.
DR   KEGG; rno:113960; -.
DR   UCSC; RGD:621753; rat.
DR   AGR; RGD:621753; -.
DR   CTD; 9578; -.
DR   RGD; 621753; Cdc42bpb.
DR   eggNOG; KOG0612; Eukaryota.
DR   GeneTree; ENSGT01030000234517; -.
DR   HOGENOM; CLU_000288_140_3_1; -.
DR   InParanoid; Q7TT49; -.
DR   OMA; CGRSHHV; -.
DR   OrthoDB; 988261at2759; -.
DR   PhylomeDB; Q7TT49; -.
DR   TreeFam; TF313551; -.
DR   Reactome; R-RNO-9013406; RHOQ GTPase cycle.
DR   PRO; PR:Q7TT49; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000009675; Expressed in frontal cortex and 19 other cell types or tissues.
DR   ExpressionAtlas; Q7TT49; baseline and differential.
DR   GO; GO:0042641; C:actomyosin; IDA:UniProtKB.
DR   GO; GO:0031252; C:cell leading edge; ISS:UniProtKB.
DR   GO; GO:0005911; C:cell-cell junction; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IBA:GO_Central.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:RGD.
DR   GO; GO:0031267; F:small GTPase binding; IDA:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IMP:RGD.
DR   GO; GO:0031032; P:actomyosin structure organization; IMP:UniProtKB.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   CDD; cd20865; C1_MRCKbeta; 1.
DR   CDD; cd00132; CRIB; 1.
DR   CDD; cd01243; PH_MRCK; 1.
DR   CDD; cd05624; STKc_MRCK_beta; 1.
DR   Gene3D; 1.20.5.340; -; 1.
DR   Gene3D; 3.30.60.20; -; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR001180; CNH_dom.
DR   InterPro; IPR000095; CRIB_dom.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR031597; KELK.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR042718; MRCKB_STKc.
DR   InterPro; IPR014930; Myotonic_dystrophy_kinase_coil.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR050839; Rho-assoc_Ser/Thr_Kinase.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR22988; MYOTONIC DYSTROPHY S/T KINASE-RELATED; 1.
DR   PANTHER; PTHR22988:SF34; SERINE_THREONINE-PROTEIN KINASE MRCK BETA; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF08826; DMPK_coil; 1.
DR   Pfam; PF15796; KELK; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00285; PBD; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF69322; Tricorn protease domain 2; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell junction; Cell membrane; Cell projection; Coiled coil;
KW   Cytoplasm; Kinase; Magnesium; Membrane; Metal-binding; Methylation;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
FT   CHAIN           1..1713
FT                   /note="Serine/threonine-protein kinase MRCK beta"
FT                   /id="PRO_0000086396"
FT   DOMAIN          76..342
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VT25,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          343..413
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   DOMAIN          1096..1215
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          1241..1515
FT                   /note="CNH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00795"
FT   DOMAIN          1585..1598
FT                   /note="CRIB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00057"
FT   ZN_FING         1026..1076
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          461..485
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          971..1014
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1615..1713
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          434..649
FT                   /evidence="ECO:0000255"
FT   COILED          681..815
FT                   /evidence="ECO:0000255"
FT   COILED          882..939
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        461..478
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1662..1676
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        200
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P54265,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10027"
FT   BINDING         82..90
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P54265,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         105
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VT25,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         221
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         233
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         239
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         423
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y5S2"
FT   MOD_RES         671
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y5S2"
FT   MOD_RES         927
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TT50"
FT   MOD_RES         954
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TT50"
FT   MOD_RES         1682
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y5S2"
FT   MOD_RES         1684
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y5S2"
FT   MOD_RES         1688
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1692
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1695
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         952
FT                   /note="F->Q: Abolishes interaction with TJP1; when
FT                   associated with Q-954."
FT                   /evidence="ECO:0000269|PubMed:21240187"
FT   MUTAGEN         954
FT                   /note="Y->Q: Abolishes interaction with TJP1; when
FT                   associated with Q-952."
FT                   /evidence="ECO:0000269|PubMed:21240187"
FT   MUTAGEN         964
FT                   /note="L->Q: Abolishes interaction with TJP1; when
FT                   associated with Q-966."
FT                   /evidence="ECO:0000269|PubMed:21240187"
FT   MUTAGEN         966
FT                   /note="F->Q: Abolishes interaction with TJP1; when
FT                   associated with Q-964."
FT                   /evidence="ECO:0000269|PubMed:21240187"
FT   CONFLICT        706
FT                   /note="A -> R (in Ref. 1; AAC02942)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1523
FT                   /note="R -> C (in Ref. 1; AAC02942)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1713 AA;  194888 MW;  80C999262C96DAA6 CRC64;
     MSAKVRLKKL EQLLLDGPWR NESSLSVETL LDVLVCLYTE CSHSALRRDK YVAEFLEWAK
     PFTQLVKDMQ LHREDFEIIK VIGRGAFGEV AVVKMKNTER IYAMKILNKW EMLKRAETAC
     FREERDVLVN GDCQWITALH YAFQDENYLY LVMDYYVGGD LLTLLSKFED KLPEDMARFY
     IGEMVLAIDS IHQLHYVHRD IKPDNVLLDV NGHIRLADFG SCLKMNDDGT VQSSVAVGTP
     DYISPEILQA MEDGMGKYGP ECDWWSLGVC MYEMLYGETP FYAESLVETY GKIMNHEERF
     QFPSHVTDVS EEAKDLIQRL ICSRERRLGQ NGIEDFKKHA FFEGLNWENI RNLEAPYIPD
     VSSPSDTSNF DVDDDVLRNI EILPPGSHTG FSGLHLPFIG FTFTTESCFS DRGSLKSMIQ
     SNTLTKDEDV QRDLENSLQI EAYERRIRRL EQEKLELSRK LQESTQTVQS LHGSTRALGN
     SNRDKEIKRL NEELERMKSK MADSNRLERQ LEDTVTLRQE HEDSTQRLKG LEKQYRLARQ
     EKEELHKQLV EASERLKSQT KELKDAHQQR KRALQEFSEL NERMAELRSQ KQKVSRQLRD
     KEEEMEVAMQ KIDSMRQDIR KSEKSRKELE ARLEDAVAEA SKERKLREHS ESFSKQMERE
     LETLKVKQGG RGPGATLEHQ QEISKIRSEL EKKVLFYEEE LVRREASHVL EVKNVKKEVH
     ESESHQLALQ KEVLMLKDKL EKSKRERHSE MEEAIGAMKD KYERERAMLF DENKKLTAEN
     EKLCSFVDKL TAQNRQLEDE LQDLASKKES VAHWEAQIAE IIQWVSDEKD ARGYLQALAS
     KMTEELETLR SSSLGSRTLD PLWKVRRSQK LDMSARLELQ SALEAEIRAK QLVHEELRKV
     KDTSLAFESK LKESEAKNRE LLEEMQSLKK RMEEKFRADT GLKLPDFQDP IFEYFNTAPL
     AHDLTFRTSS ASDQETQASK LDLSPSVSVA TSTEQQEDAA RSQQRPSTVP LPNTQALAMA
     GPKPKAHQFS IKSFPSPTQC SHCTSLMVGL IRQGYACEVC AFSCHVSCKD SAPQVCPIPP
     EQSKRPLGVD VQRGIGTAYK GYVKVPKPTG VKKGWQRAYA VVCDCKLFLY DLPEGKSTQP
     GVIASQVLDL RDDEFAVSSV LASDVIHATR RDIPCIFRVT ASLLGSPSKT SSLLILTENE
     NEKRKWVGIL EGLQAILHKN RLRSQVVHVA QEAYDSSLPL IKTVLAAAIV DGDRIAVGLE
     EGLYVIELTR DVIVRAADCK KVYQIELAPK EKLILLLCGR NHHVHLYPWT SFDGAEASNF
     DIKLPETKGC QLIATGTLRK SSSTCLFVAV KRLVLCYEIQ RTKPFHRKFN EIVAPGHVQW
     MAMFKDRLCV GYPSGFSLLS IQGDGQPLDL VNPADPSLAF LSQQSFDALC AVELKSEEYL
     LCFSHMGLYV DPQGRRSRTQ ELMWPAAPVA CSCSSSHVTV YSEYGVDVFD VRTMEWVQTI
     GLRRIRPLNS DGSLNLLGCE PPRLIYFKNK FSGTVLNVPD TSDNSKKQML RTRSKRRFVF
     KVPEEERLQQ RREMLRDPEL RSKMISNPTN FNHVAHMGPG DGMQVLMDLP LSAAPTAQEE
     KQGPAPTGLP RQLPSRNKPY VSWPSSGGSE PGVPVPLRSM SDPDQDFDKE PDSDSTKHST
     PSNSSNPSGP PSPNSPHRSQ LPLEGLDQPA CDA
//
